Breakthrough in Presbyopia Treatment: Entod Pharmaceuticals' PresVu Eye Drops Approved by DCGI

Entode Pharmaceuticals' innovative 'PresVu Eye Drops' has been approved by the DCGI, marking a significant advancement in presbyopia treatment. This solution offers rapid near vision improvement, long-term effects, and eye lubrication, presenting a non-invasive alternative to traditional treatments. With competitive pricing and patent pending, it promises to enhance the quality of life for presbyopia patients.